Effects of the co-polymer surfactant, Pluronic® F-68, on platelet aggregation in human whole blood

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 5, 1997, Pages 493-499

  Edwards, C M ^a   Heptinstall, S ^a   Lowe, K C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; HEMODYNAMICS; ORGANIC POLYMERS; SURFACE ACTIVE AGENTS;

HUMAN WHOLE BLOOD; PLATELET AGGREGATION;

BLOOD;

ADENOSINE DIPHOSPHATE; PERFLUORO COMPOUND; POLOXAMER; SURFACTANT;

ARTICLE; BLOOD; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISCHEMIA; MICROCIRCULATION; THROMBOCYTE AGGREGATION; TISSUE PERFUSION;

EID: 0030853555     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709118940     Document Type: Article

References (13)

1. Carter, C., Fisher, T.C, Hamai, H., Johnson, C.S., Meiselman, H.J., Nash, G.B. & Stuart, J. Haemorheological effects of a nonionic copolymer surfactant (Poloxamer 188). Clin. Hemorheol. 12, 109-120 (1992).
2. Schaer, G.L., Hursey, T.L., Abrahams, S.L., Buddemeier, K., Ennis, B., Rodriguez, R., Hubbell, J.P., Moy, J. and Parrillo, J.E. Reduction in reperfusion-induced myocardial injury in dogs by RheothRx® Injection (Poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation 90, 2964-2975 (1994).
3. Smith, C.M., Hebbel, R.P., Tukey, D.P., Clawson, C.C., White, J.G. & Vercellotti, G.M. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes. Blood 69, 1631-1636 (1987).
4. Lowe, K.C. Perfluorochemical blood substitutes: circulatory and biomedical applications. Clin. Hemorheol. 12, 141-156 (1992).
5. Lowe, K.C. Perfluorochemicals in vascular medicine. Vasc. Med. Rev. 5, 15-32 (1994).
6. Lowe, K.C. Properties and biomedical applications of perfluorochemicals and their emulsions. In Organofluorine Chemistry: Principles and Commercial Applications, Banks, R.E., Smart, B.E., Tatlow, J.C. (Eds.), pp. 555-577. New York, Plenum, 1994.
7. 2) to inhibit platelet-aggregation and to prevent restenosis after coronary angioplasty. Results of a randomised placebo-controlled trial. Br. Heart J. 71, 7-15 (1995).
8. Benner, K.U., Gaehtgens P. & Frede K.E. Aggregation of human red blood (RBC) cells and platelets and its reversal by a surface-active substance (Pluronic® F-68). Bibl. Anat. 12, 208-215 (1973).
9. Edwards, C.M., Heptinstall, S. and Lowe, K.C. Inhibitory effects of the co-polymer surfactant, Pluronic F-68, on spontaneous platelet aggregation in human whole blood. Br. J. Pharmacol. 116, 159P (1995).
10. Edwards, C.M., May, J.A. Heptinstall, S. and Lowe, K.C. Effects of Pluronic® F-68 (Poloxamer 188) on platelet aggregation in human whole blood. Thromb. Res. 81, 511-512 (1996).
11. Bentley, P.K., Davis, S.S., Johnson, O.L., Lowe, K.C. & Washington, C. Purification of Pluronic F-68 for perfluorochemical emulsification. J. Pharm. Pharmacol. 41, 661-663 (1989).
12. Snedecor, G.W. and Cochran, W.G. Statistical Methods, 8th Edn., Ames, Iowa State College Press, 1989.
13. Hunter, R.L., Bennett, B. & Check, I.J. The effect of poloxamer 188 on the rate of in vitro thrombolysis mediated by t-PA and streptokinase. Fibrinolysis 4, 117-123 (1990).